Specialty

Boston Scientific Corporation today announced it has received approval from the U.S. Food and Drug Administration to market its TAXUS® Liberte® Atom™ Paclitaxel-Eluting Coronary Stent System.

Premier Purchasing Partners, LP, today announced new agreements for spinal implants and related products have been awarded to Aesculap Implant Systems Inc. of Center Valley, Pa.; DePuy Spine of Raynham, Mass.; and Medtronic Sofamor Danek of Memphis, Tenn.

Aircraft Medical, the UK medical devices company, today announces that it has entered the emergent Depth of Anaesthesia monitoring market with the acquisition of Morpheus Medical, the Barcelona-based developer of medical equipment.

Boston Scientific Corporation today welcomed publication of results from the ISAT clinical trial showing patients with a ruptured intracranial aneurysm treated with endovascular coil embolization are 23 percent less likely to die within five years compared to patients who undergo surgical clipping.

Invatec, a comprehensive innovator of interventional products, today announced the availability of its newly CE marked coronary balloon, the IN.PACT™ Falcon paclitaxel-eluting PTCA balloon catheter at the EuroPCR Congress 2009 in Barcelona, Spain.

Ingen Technologies, Inc. announced today agreements with Emergo Global Consulting LLC to prepare and register the ISO and CE mark certifications required to market and sell Oxyview in Europe, Asia and Canada.

Tornier, Inc., a global leader in extremities orthopaedics, announced today the first human implant of a shoulder arthroplasty prosthesis based on the company’s proprietary pyrocarbon technology.

Smith & Nephew’s Endoscopy Division today announced the launch of the BICEPTOR Tenodesis System to treat injuries to the biceps tendon in the shoulder.

Medtronic, Inc. announced new data presented today on the safety and effectiveness of Medtronic’s CoreValve system via a novel, subclavian approach.

Direct Flow Medical, Inc. a privately held, emerging medical device Company developing a next generation, minimally invasive implant to treat patients with heart valve disease announced today the first human use of their new 18 French Percutaneous Aortic Valve (PAV) System.

Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeich’s Genous™ Bio-engineered R stent™ Compared to Drug-Eluting Stents.

Edwards Lifesciences Corporation, the world leader in the science of heart valves, today announced at EuroPCR 2009 the results from its first post-market study of consecutively enrolled Edwards SAPIEN transcatheter aortic valve patients.

MEDRAD Interventional™/Possis® announced that it has reached key milestones in bringing the Paccocath® Technology closer to market.

Medtronic, Inc. announced completion of enrollment in the TTOP-AF (Tailored Treatment of Permanent Atrial Fibrillation) clinical trial. The study is evaluating the use of the Medtronic Ablation Frontiers Cardiac Ablation System, for the treatment of continuous atrial fibrillation.

Invatec, a comprehensive innovator of interventional products, today announced the availability of its newly CE marked coronary balloon, the IN.PACT™ Falcon paclitaxel-eluting PTCA balloon catheter at the EuroPCR Congress 2009 in Barcelona, Spain.

Boston Scientific Corporation today welcomed the launch of a new website, www.syntaxscore.com, dedicated to the understanding and use of the SYNTAX Score™, a novel angiographic tool used to measure the complexity of coronary artery disease.